At NINGBO INNO PHARMCHEM CO.,LTD., we recognize that the success of pharmaceutical development hinges on the quality and precision of its constituent chemicals. Methyl 4-(Bromomethyl)-3-Methoxybenzoate, identified by CAS number 70264-94-7, is a prime example of such a critical pharmaceutical intermediate. Its paramount importance lies in its integral role in the synthesis of Zafirlukast, a key medication in the treatment of chronic asthma. This article delves into the precise chemical attributes of this compound and its substantial impact on pharmaceutical manufacturing.

The physical presentation of Methyl 4-(Bromomethyl)-3-Methoxybenzoate as a white to off-white crystalline powder signifies its high purity, a crucial characteristic for any compound intended for pharmaceutical use. Its molecular formula, C10H11BrO3, and a molecular weight of 259.096, provide the foundational data for its predictable behavior in complex organic synthesis reactions. The assay of ≥98.0% ensures that manufacturers engaged in Zafirlukast intermediate synthesis can rely on its consistent quality and performance, making it a preferred choice for critical production steps.

The primary and most significant application of Methyl 4-(Bromomethyl)-3-Methoxybenzoate is its indispensable function in the production pathway of Zafirlukast. Zafirlukast is a highly effective selective leukotriene receptor antagonist that plays a crucial role in managing chronic asthma. Leukotrienes are natural substances in the body that can trigger asthma symptoms by causing inflammation and narrowing of the airways. By blocking the action of these leukotrienes, Zafirlukast helps to prevent and control asthma. The presence of the bromomethyl group in Methyl 4-(Bromomethyl)-3-Methoxybenzoate is vital for enabling the specific chemical reactions required to construct the Zafirlukast molecule, thus cementing its status as a critical asthma medication intermediate.

The global pharmaceutical industry's demand for reliable and high-quality materials is continuously met by suppliers like NINGBO INNO PHARMCHEM CO.,LTD. We are committed to providing high purity methyl 4-(bromomethyl)-3-methoxybenzoate, ensuring that our clients have access to materials that meet the exacting standards of the industry. The consistent quality of this pharmaceutical intermediate chemical is essential for the successful and efficient Zafirlukast intermediate synthesis, contributing directly to the availability of vital medications.

Furthermore, Methyl 4-(Bromomethyl)-3-Methoxybenzoate is a valuable compound within the broader spectrum of organic synthesis and the fine chemical market. Its precisely defined chemical structure and reactivity make it a versatile tool for researchers and chemists developing new therapeutic agents or optimizing existing manufacturing processes. The dependable supply of fine chemical CAS 70264-94-7 facilitates innovation and supports the advancement of chemical sciences.

At NINGBO INNO PHARMCHEM CO.,LTD., we pride ourselves on our dedication to supporting the pharmaceutical sector with top-tier chemical intermediates. Our expertise in chemical synthesis and our unwavering commitment to quality assurance make us a trusted partner for businesses worldwide. For any inquiries concerning Zafirlukast intermediate synthesis, custom chemical solutions, or our extensive portfolio of pharmaceutical intermediates, we encourage you to contact us. We are poised to deliver tailored solutions and comprehensive quotations to meet your specific project requirements.